Fluconazole, Serum or Plasma
Also known as: Diflucan®
Use
Treatment of candidiasis, cryptococcal meningitis, and antifungal prophylaxis in allogeneic bone marrow transplant recipients.
Special Instructions
Not provided.
Limitations
The method applied for this test, while not FDA-approved, has been developed and the performance characteristics determined by LabCorp, as the FDA has ruled such clearance for this test unnecessary. Despite the absence of direct FDA validation, LabCorp ensures analytical fidelity through their internal validation processes. Test results need careful interpretation as there isn't a direct correlation established between drug concentrations and clinical efficacy or toxicity. External factors such as renal dysfunction or the presence of renal replacement therapy can influence drug exposure and should be considered when interpreting results.
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 10987-6 - Fluconazole SerPl-mCnc
- 10987-6 - Fluconazole SerPl-mCnc
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Red-top tube
Collection Instructions
Transfer separated serum to a plastic transport tube. Do not use a gel-barrier tube due to potential slow absorption of the drug by the gel.
Storage Instructions
Refrigerate. Stable for 14 days at room temperature, refrigerated, or frozen.
Causes for Rejection
Gel-barrier tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Other tests from different labs that may be relevant